Antenatal corticosteroids for women at risk of imminent preterm birth in 7 sub-Saharan African countries: a policy and implementation landscape analysis

D Greensides, J Robb-McCord, A Noriega… - Global Health: Science …, 2018 - ghspjournal.org
Background: Every year approximately 15 million babies are born prematurely and nearly 1
million die due to preterm birth complications. Evidence shows that antenatal corticosteroids …

[HTML][HTML] Use of antenatal corticosteroids at health facilities and communities in low-and-middle income countries

M Berrueta, J Hemingway-Foday, VR Thorsten… - Reproductive health, 2016 - Springer
Background Antenatal corticosteroids (ACS) for women at high risk of preterm birth is an
effective intervention to reduce neonatal mortality among preterm babies delivered in …

[HTML][HTML] Antenatal corticosteroids for management of preterm birth: a multi-country analysis of health system bottlenecks and potential solutions

G Liu, J Segrè, AM Gülmezoglu, M Mathai… - BMC pregnancy and …, 2015 - Springer
Background Preterm birth complications are the leading cause of deaths for children under
five years. Antenatal corticosteroids (ACS) are effective at reducing mortality and serious …

[HTML][HTML] Reducing neonatal mortality associated with preterm birth: gaps in knowledge of the impact of antenatal corticosteroids on preterm birth outcomes in low …

EM McClure, RL Goldenberg, AH Jobe, M Miodovnik… - Reproductive health, 2016 - Springer
Abstract The Global Network's Antenatal Corticosteroids Trial (ACT), was a multi-country,
cluster-randomized trial to improve appropriate use of antenatal corticosteroids (ACS) in low …

Antenatal corticosteroids for women at risk of imminent preterm birth in low-resource countries: the case for equipoise and the need for efficacy trials

JP Vogel, OT Oladapo, C Pileggi-Castro… - BMJ global …, 2017 - gh.bmj.com
The scientific basis for antenatal corticosteroids (ACS) for women at risk of preterm birth has
rapidly changed in recent years. Two landmark trials—the Antenatal Corticosteroid Trial and …

[HTML][HTML] The World Health Organization ACTION-I (Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns) Trial: a multi-country, multi-centre, two …

Trials, 2019 - Springer
Background Antenatal corticosteroids (ACS) have long been regarded as a cornerstone
intervention in mitigating the adverse effects of a preterm birth. However, the safety and …

A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm …

F Althabe, JM Belizán, EM McClure… - The Lancet, 2015 - thelancet.com
Background Antenatal corticosteroids for pregnant women at risk of preterm birth are among
the most effective hospital-based interventions to reduce neonatal mortality. We aimed to …

[HTML][HTML] Readiness to provide antenatal corticosteroids for threatened preterm birth in public health facilities in Northern India

A Kankaria, M Duggal, A Chauhan… - … Health: Science and …, 2021 - ghspjournal.org
ABSTRACT Introduction: In 2014, the Government of India (GOI) released operational
guidelines on the use of antenatal corticosteroids (ACS) in preterm labor. However, without …

[HTML][HTML] The Antenatal Corticosteroids Trial (ACT): a secondary analysis to explore site differences in a multi-country trial

K Klein, EM McClure, D Colaci, V Thorsten… - Reproductive health, 2016 - Springer
Abstract Background The Antenatal Corticosteroid Trial (ACT) assessed the feasibility,
effectiveness, and safety of a multifaceted intervention to increase the use of antenatal …

[HTML][HTML] Association between antenatal corticosteroid use and perinatal mortality among preterm births in hospitals in Tanzania

S Mwita, E Konje, B Kamala, A Izina, S Kilonzo… - Plos one, 2021 - journals.plos.org
Objectives The primary aims of this study were to investigate if exposure to antenatal
corticosteroids (ACS) was associated with lower rates of perinatal mortality (primary …